DEF 14A: Fonar Corporation Announces Annual Meeting of Stockholders and Releases Proxy Statement

Fonar Corporation will hold its annual meeting of stockholders on May 20, 2024, to elect directors, approve executive compensation, and ratify the selection of auditors.

Summary

• Fonar Corporation is holding its Annual Meeting of Stockholders on May 20, 2024, at the Hilton Long Island Huntington Hotel in Melville, New York.
• The meeting will include the election of five directors to the Board of Directors.
• Stockholders will vote on an advisory basis regarding the compensation of the company's named executive officers.
• They will also recommend the frequency of the advisory vote on executive compensation (every year, two years, or three years).
• The selection of Marcum LLP as the company's auditors for the fiscal year ending June 30, 2024, will be ratified.
• Only stockholders of record as of March 25, 2024, are entitled to vote at the meeting.
• The proxy statement is being made available to shareholders on or about April 8, 2024.
• The company is posting the Notice of Annual Meeting and Proxy Statement, together with the Annual Report on the internet.
• At the close of business on March 25, 2024, there were 6,327,570 shares of Common Stock, 146 shares of Class B Common Stock, and 382,513 shares of Class C Common Stock outstanding.
• The 313,438 shares of Class A Nonvoting Preferred Stock are not entitled to vote.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the company's history, ongoing research, and commitment to growth. However, it also acknowledges challenges and competition within the industry.

Positives

• The Board of Directors recommends a vote FOR all of the nominees for the directors of the company.
• The Board of Directors recommends a vote FOR the proposal to ratify the selection of auditors.
• The Board of Directors recommends that stockholders vote to conduct future advisory votes on the compensation of the company's named executive officers EVERY YEAR.

Future Outlook

The company expresses a commitment to continuing growth for years to come, with HMCA managing 42 MRI scanners and continuing product innovation and research.

Management Comments

• Timothy Damadian believes that to properly understand Fonar, it must be done in the light of the company's extraordinary history.
• Timothy Damadian states that FONAR will continue its tradition of product innovation and research.
• Timothy Damadian states that HMCA is committed to continuing growth for years to come.

Industry Context

The document highlights Fonar's position as the 'World's First MRI Company' and its ongoing efforts to innovate within the diagnostic imaging industry, particularly with its UPRIGHT MRI technology.

Comparison to Industry Standards

• The document mentions competition from major players like Siemens, General Electric, Hitachi, Philips, and Canon in the MRI market.
• It also acknowledges competition from Paramed and Esaote in the upright, weight-bearing MRI market, but asserts Fonar's competitive advantages.
• The document emphasizes the unique capabilities of Fonar's UPRIGHT MRI compared to conventional MRI scanners.

Related Party Transactions

• Timothy Damadian currently owns three HMCA-managed MRI facilities in Florida, with management fees subject to annual adjustment.

Stakeholder Impact

• Shareholders are provided with information to make informed decisions regarding director elections and executive compensation.
• Employees are subject to a code of ethics and have access to a 401(k) plan.
• Customers (patients and physicians) benefit from the company's commitment to product innovation and research.

Next Steps

• Stockholders are urged to vote their shares by internet, phone, or mail.
• Interested parties can contact Daniel Culver to schedule a visit to the Raymond V. Damadian, M.D. Memorial Museum.

Key Dates

Keywords

annual meeting, proxy statement, directors, executive compensation, auditors, stockholders, voting, Fonar Corporation, MRI